Chester Tennyson v. HHS - Influenza, Guillain-Barré syndrome (2024)
Case summary [AI summaries can sometimes make mistakes]
Chester Tennyson filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging he developed Guillain-Barré syndrome (GBS) as a result of an influenza vaccine administered on November 2, 2018. The respondent, the Secretary of Health and Human Services, conceded that Mr.
Tennyson was entitled to compensation, stating that his condition met the criteria set forth in the revised Vaccine Injury Table and the Qualifications and Aids to Interpretation. A Ruling on Entitlement was issued on March 23, 2023, confirming his eligibility for compensation.
As the parties could not resolve damages informally, a hearing was held on June 28, 2024. Mr.
Tennyson requested $150,000 for pain and suffering and $358.10 for medical expenses. The respondent recommended $72,500 for pain and suffering but agreed to the medical expenses.
The court awarded Mr. Tennyson $110,000 for pain and suffering and $358.10 for unreimbursable medical expenses, totaling $110,358.10, to be paid as a lump sum.
This award covers all damages available under Section 15(a) of the Vaccine Act.